Pretransplant Immunologic Risk Assessment of Kidney Transplant Recipients With Donor-Specific Anti–Human Leukocyte Antigen Antibodies-Reference-Cited by-同舟云学术

Pretransplant Immunologic Risk Assessment of Kidney Transplant Recipients With Donor-Specific Anti–Human Leukocyte Antigen Antibodies

Published:2014-11-27 Issue:10 Volume:98 Page:1082-1088
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Marfo Kwaku,Ajaimy Maria,Colovai Adriana,Kayler Liise,Greenstein Stuart,Lubetzky Michelle,Gupta Anjali,Kamal Layla,de Boccardo Graciela,Masiakos Peter,Kinkhabwala Milan,Akalin Enver

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference34 articles.

1. Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients.;Ling;Hum Immunol,2012

2. Desensitization protocols and their outcome.;Marfo;Clin J Am Soc Nephrol,2011

3. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.;Jordan;J Am Soc Nephrol,2004

4. Rituximab and intravenous immune globulin for desensitization during renal transplantation.;Vo;N Engl J Med,2008

5. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.;Vo;Transplantation,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor‐specific anti HLA antibodies;HLA;2024-06

2. Current Strategies in Immune Modulation and Desensitization Protocols;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

3. The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice;Transplant International;2023-07-25

4. Impact of pre‐transplant donor specific antibodies detected by Luminex with negative microlymphocytotoxicity assay and flow crossmatch in live‐related renal transplant recipients;Clinical Transplantation;2023-02-23

5. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings–a single-center experience;Transplant Immunology;2022-06